Dan Levitt
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- MRI in cancer diagnosis
-
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
Papers in
-
- Allergic Rhinitis and Sensitization 3
-
- T-cell and B-cell Immunology 2
- Co-authors
- Gary M. Clark (1 shared paper)Feng Wu (1 shared paper)Charles Kent Osborne (1 shared paper)Daniel Gennevois (1 shared paper)Joseph Eiden (1 shared paper)Simon Dobson (1 shared paper)Gary Van Nest (1 shared paper)Bruce R. Smith (1 shared paper)
- Journals
- Journal of Allergy and Clinical Immunology (3 papers)The Journal of Immunology (2 papers)JNCI Journal of the National Cancer Institute (2 papers)Journal of Immunotherapy (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- United StatesNetherlandsBelgium
In The Last Decade
Dan Levitt
16 papers receiving 651 citations
Peers
Comparison fields: 5 of 57
- Radiology, Nuclear Medicine and Imaging 173
- Immunology 134
- Immunology and Allergy 24
- Physiology 104
- Oncology 73
Countries citing papers authored by Dan Levitt
This map shows the geographic impact of Dan Levitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Levitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Levitt more than expected).
Fields of papers citing papers by Dan Levitt
This network shows the impact of papers produced by Dan Levitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Levitt. The network helps show where Dan Levitt may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Levitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 220 | |
| 2 | 1997 | 125 | |
| 3 | 2005 | 117 | |
| 4 | 1990 | 57 | |
| 5 | 2005 | 39 | |
| 6 | 1999 | 36 | |
| 7 | 1991 | 24 | |
| 8 | 1993 | 23 | |
| 9 | Anti-VEGF Antibody HuMV833: an EORTC Biological Treatment Development Group Phase I Toxicity, Pharmacokinetic and Pharmacodynamic Study. | 2001 | 17 |
| 10 | 2006 | 14 | |
| 11 | 1986 | 13 | |
| 12 | 2006 | 5 | |
| 13 | 1987 | 4 | |
| 14 | Interferon-alpha and interleukin-2 in the treatment of renal cell cancer. | 1990 | 3 |
| 15 | 2005 | 3 | |
| 16 | 2001 | 1 |
About Dan Levitt
Dan Levitt is a scholar working on Immunology and Allergy, Immunology, Radiology, Nuclear Medicine and Imaging, Microbiology and Molecular Biology, having authored 16 papers that have together received 701 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Allergic Rhinitis and Sensitization (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), T-cell and B-cell Immunology (2 papers), Renal cell carcinoma treatment (2 papers), Telomeres, Telomerase, and Senescence (1 paper), Reproductive tract infections research (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (173 citations), Immunology (134 citations), Immunology and Allergy (24 citations), Physiology (104 citations) and Oncology (73 citations). Dan Levitt has collaborated with scholars based in United States, Netherlands and Belgium. Frequent co-authors include Gary M. Clark, Feng Wu, Charles Kent Osborne, Daniel Gennevois, Joseph Eiden, Simon Dobson, Gary Van Nest, Bruce R. Smith, Scott A. Halperin and Shelly McNeil. Their work appears in journals such as Journal of Allergy and Clinical Immunology, The Journal of Immunology, JNCI Journal of the National Cancer Institute, Journal of Immunotherapy and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.